Company Overview
OCULAR THERAPEUTIX, INC
OCULRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
52M
2025 FY
Net Income
-266M
2025 FY
Shares Outstanding
187M
2025 FY
EPS
-1.42USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1393434
Exchange
Nasdaq
Location
US